Skip to main content
SpringerLink
Log in

Proteomic approaches to biomarker discovery in lung cancers by SELDI technology

  • Published:
Science in China Series C: Life Sciences Aims and scope Submit manuscript

Abstract

The purpose of the present work is to identify protein profiles that could be used to discover specific biomarkers in serum and discriminate lung cancer. Thirty serum samples from patients with lung cancer (15 cases of primary brochogenic carcinoma, 9 cases of metastasis lung cancer and 6 cases of lung cancer after chemotherapy) and twelve from healthy individuals were analyzed by SELDI (Surfaced Enhanced Laser Desorption/Ionization) technology. Anion-exchange columns were used to fractionate the sera with 6 designated pH washing solutions. Two types of protein chip arrays, IMAC-Cu and WCX2, were employed. Protein chips were examined in PBSII ProteinChip Reader (Ciphergen Biosystems Inc.) and the resulting profiles between cancer and normal were analyzed with Biomarker Wizard System. In total, 15 potential lung cancer biomarkers, of which 6 were up-regulated and 9 were down-regulated, were discovered in the serum samples from patients with lung cancer. 5 of 15 these biomarkers were able to be detected on both WCX2 and IMAC-Cu protein chips. The sensitivities provided by the individual markers range from 44.8% to 93.1% and the specificities were 85.0%–94.4%. Our results suggest that serum is a capable resource for detection of lung cancer with specific biomarkers. Moreover, protein chip array system was shown to be a useful tool for identification, as well as detection of disease biomarkers in sera.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Smith, R. A., Mettlin, C. S., Davis, K. J. et al., American cancer society guidelines for the early detection of cancer, CA Cancer J. Clin., 2000, 50(1): 34–49.

    Article  PubMed  CAS  Google Scholar 

  2. Eggeling, F. V., Davies, H., Lomas, L. et al., Tissue-specific microdissection coupled with ProteinChip array technologies: Applications in cancer research, Biotechniques, 2000, 29(5): 1066–1070.

    Google Scholar 

  3. Bichsel, V. E., Liotta, L. A., Petricoin, E. F. et al., Cancer proteomics: From biomarker discovery to signal pathway profiling, Cancer J., 2001, 7(1): 69–78.

    PubMed  CAS  Google Scholar 

  4. He, D., Xiao, X., SELDI protein chip technology and its applications in proteomics, Modern Instruments (in Chinese), 2002, 1: 1–4.

    CAS  Google Scholar 

  5. Eggeling, F. V., Junker, K., Fiedler, W. et al., Mass spectrometry meets chip technology: A new proteomic tool in cancer research? Electrophoresis, 2001, 22: 2898–2902.

    Article  Google Scholar 

  6. Paweletz, C., Trock, B., Pennanen, M. et al., Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: Potential for new biomarkers to aid in the diagnosis of breast cancer, Dis. Marker, 2001, 17(4): 301–307.

    CAS  Google Scholar 

  7. Vlahou, A., Schellhammer, P. F., Mendrinos, S. et al., Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine, American Journal of Pathology, 2001, 158(4): 1491–1502.

    PubMed  CAS  Google Scholar 

  8. Petricoin, E. F., Ardekani, A. M., Hitt, B. A. et al., Use of proteomic patterns in serum to identify ovarian cancer, The Lancet, 2002, 359: 572–577.

    Article  CAS  Google Scholar 

  9. Li Peiwen, Diagnosis and Treatment of Lung Cancer (in Chinese), Beijing: Traditional Chinese Medicine Press of China, 2001, Chapter 2.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Cell Biology, College of Life Sciences, Beijing Normal University, Universities’ Confederated Institute of Proteomics, 100875, Beijing, China

    Xiao Xueyuan & He Dacheng

  2. Affiliated Beijing Tiantan Hospital, Capital University of Medical Sciences, 100050, Beijing, China

    Wei Xiuping

Authors
  1. Xiao Xueyuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei Xiuping
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. He Dacheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to He Dacheng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xiao, X., Wei, X. & He, D. Proteomic approaches to biomarker discovery in lung cancers by SELDI technology. Sci. China Ser. C.-Life Sci. 46, 531–537 (2003). https://doi.org/10.1360/02yc0208

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1360/02yc0208

Keywords

Search

Navigation